Prevena™ Incision Management System

DEVICE3 trials

Sponsors

Solventum US LLC, Masonic Cancer Center, University of Minnesota, Progenerative Medical, Inc

Conditions

Gynecologic NeoplasmsObesityPostoperative ComplicationsSurgical Site Occurences After SternotomySurgical WoundWound Infection

Phase 1

Regenn® Therapy System Safety Study

Active, not recruitingNCT06259409

Progenerative Medical, IncSurgical Wound

Start: 2024-10-09End: 2026-12-01Target: 30Updated: 2026-08-27

Unknown Phase

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

TerminatedNCT02195310

Solventum US LLCSurgical Site Occurences After Sternotomy, Wound Infection

Start: 2013-11-12End: 2016-10-17Updated: 2024-10-02

Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients

CompletedNCT02309944

Masonic Cancer Center, University of MinnesotaGynecologic Neoplasms, Obesity, Postoperative Complications

Start: 2015-05-31End: 2020-06-30Updated: 2020-07-27